O. Zalepukhina

Safety and efficacy of a long‐acting liposomal formulation of plasma‐derived factor VIII in haemophilia A patients

J. Spira, N. Zozulya, V. Zorenko, 2012, British journal of haematology.

Efficacy and safety of the drug Octofactor in prophylactic treatment in patients with severe haemophilia A

V. Zorenko, G. Mishin, A. Shuster, 2018, Russian Journal of Children Hematology and Oncology.

Safety and Efficiency of New Nonacog Alfa Drug in the Treatment of Bleeding Episodes in Patients with Severe and Moderate Hemophilia B

S. Lukyanov, V. Zorenko, G. Mishin, 2015 .

Safety and Efficacy of New Nonacog Alfa Drug (Innonafactor) in Prophylactic Treatment in Patients with Severe and Moderate Hemophilia B

S. Lukyanov, V. Zorenko, G. Mishin, 2015 .

Results of a prospective observation on the use of a coagulation factor concentrate VIII concentrate (Octanate®) for the induction of immunological tolerance in patients with an inhibitory form of hemophilia A

V. V. Vdovin, N. Zozulya, P. Svirin, 2020, Russian Journal of Pediatric Hematology and Oncology.